Article
High Content Screening and Proteomic Analysis Identify a Kinase Inhibitor that…
medRxiv · 2021 · Antoniou, N.; Prodromidou, K.; Kouroupi, G.; Samiotaki, M.; Panayotou, G.; Xilouri, M.; Stefanis, L.; Grailhe, R.; Taoufik, E.; Matsas, R.
Key facts
| Title | High Content Screening and Proteomic Analysis Identify a Kinase Inhibitor that rescuespathological phenotypes in a Patient-Derived Model of Parkinson's Disease |
|---|---|
| First author | Antoniou, N.; Prodromidou, K.; Kouroupi, G.; Samiotaki, M.; Panayotou, G.; Xilouri, M.; Stefanis, L.; Grailhe, R.; Taoufik, E.; Matsas, R. |
| Journal | medRxiv |
| Published | Apr 14, 2021 |
| DOI | 10.1101/2020.06.12.148031 |
| Devices mentioned | DEN000008, K022086, K103302, K133972, K142003, K170858, K191495, K192440, K192932, K212956 |
| Product codes mentioned | JCI, KIT, NDS, NJT, OOI |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1